Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6297333 | 0.79 | MALT1 (0.39) | RECQLGAACYP1A2ALDH1A1CYP2C9 | |
| SCHEMBL5572000 | 0.76 | KIF11 (0.52) | KIF11 | |
| SCHEMBL2538210 | 0.73 | GAA (0.65) | RECQLGAACYP1A2ALDH1A1TDP1 | |
| SCHEMBL6570943 | 0.73 | GAA (0.74) | RECQLGAACYP1A2ALDH1A1TDP1 | |
| SCHEMBL10037241 | 0.72 | GAA (0.54) | RECQLGAACYP1A2ALDH1A1TDP1 | |
| SCHEMBL17264136 | 0.71 | GAA (0.61) | RECQLGAACYP1A2ALDH1A1TDP1 | |
| SCHEMBL2566077 | 0.70 | GAA (0.69) | RECQLGAACYP1A2ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL29556018 | 0.69 | GAA (0.67) | RECQLGAACYP1A2ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL5418885 | 0.69 | GAA (0.67) | RECQLGAACYP1A2ALDH1A1TDP1 | |
| SCHEMBL24507059 | 0.69 | GAA (0.71) | RECQLGAACYP1A2ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6942966-B1 | libraries formed by permutations; combinatorial chemistry; drug screening | ISIS PHARMACEUTICALS, INC. (US) | 2005-09-13 | — | — | US | disclosed |
| US-6559303-B1 | Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical | ISIS PHARMACEUTICALS, INC. | 2003-05-06 | — | — | US | disclosed |
| US-6207826-B1 | Macrocyclic compounds having nitrogen-containing linkages | ISIS PHARMACEUTICALS, INC. | 2001-03-27 | — | — | US | disclosed |
| EP-0817787-A4 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS INC (US) | 2000-09-13 | — | — | EP | disclosed |
| US-6107482-A | LARGE CYCLIC STRUCTURES INTERRUPTED BY AT LEAST ONE RING SYSTEM WHICH INCLUDES TWO BRIDGEHEAD ATOMS; CONTAIN PLURALITY NITROGENOUS SITES THAT ARE DERIVATIZED SUCH AS WITH DRUGS, NUCLEIC ACIDS, PROTEINS; USE IN LIBRARIES | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-22 | — | — | US | disclosed |
| WO-1998010286-A1 | METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1998-03-12 | — | — | WO | disclosed |
| EP-0817787-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030377-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-03 | — | — | WO | disclosed |